Biogen (BIIB) Other Non-Current Assets (2009 - 2026)

Biogen (BIIB) has reported Other Non-Current Assets for 18 consecutive years, with $777.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 39.06% year-over-year to $777.5 million; the TTM figure through Mar 2026 stood at $777.5 million (up 39.06% YoY), while the FY2025 annual figure was $750.6 million, up 33.92% from the prior year.
• Other Non-Current Assets came in at $777.5 million for Q1 2026 at Biogen, up from $750.6 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $1.8 billion in Q1 2022, with the low at $559.1 million in Q1 2025.
• Average Other Non-Current Assets over 5 years is $965.9 million, with a median of $750.6 million recorded in 2025.
• Across the five-year window, Other Non-Current Assets sank 53.21% in 2023 and surged 39.06% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $1.5 billion in 2022, then plunged by 51.28% to $745.0 million in 2023, then slipped by 24.77% to $560.5 million in 2024, then surged by 33.92% to $750.6 million in 2025, then increased by 3.58% to $777.5 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $777.5 million, $750.6 million, and $729.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.